Furthermore, intravitreal injection of Magnesium Acetyltaurate (MgAT) provided significant neuroprotective effects against ET-1 induced damage in the retina by suppressing the neuroinflammatory reaction and offering a way to protect against glaucoma-related retinal damage and preserve vision by addressing both vascular dysfunction and oxidative stress [58,59]. The gene discussed is EDN1; the disease is glaucoma.